These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Impact of contrast-induced acute kidney injury on outcomes in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Kume K, Yasuoka Y, Adachi H, Noda Y, Hattori S, Araki R, Kohama Y, Imanaka T, Matsutera R, Kosugi M, Sasaki T. Cardiovasc Revasc Med; 2013; 14(5):253-7. PubMed ID: 23993293 [Abstract] [Full Text] [Related]
3. Contrast Volume to Glomerular Filtration Ratio and Acute Kidney Injury among ST-Segment Elevation Myocardial Infarction Patients Treated with Primary Percutaneous Coronary Intervention. Zahler D, Rozenfeld KL, Merdler I, Peri Y, Shacham Y. Cardiorenal Med; 2020; 10(2):108-115. PubMed ID: 31801134 [Abstract] [Full Text] [Related]
4. Association of contrast-induced acute kidney injury with long-term cardiovascular events in acute coronary syndrome patients with chronic kidney disease undergoing emergent percutaneous coronary intervention. Watabe H, Sato A, Hoshi T, Takeyasu N, Abe D, Akiyama D, Kakefuda Y, Nishina H, Noguchi Y, Aonuma K. Int J Cardiol; 2014 Jun 01; 174(1):57-63. PubMed ID: 24726211 [Abstract] [Full Text] [Related]
5. Contrast-Induced Nephropathy in STEMI Patients With and Without Chronic Kidney Disease. Jain T, Shah S, Shah J, Jacobsen G, Khandelwal A. Crit Pathw Cardiol; 2018 Mar 01; 17(1):25-31. PubMed ID: 29432373 [Abstract] [Full Text] [Related]
6. Predictors of outcomes of contrast-induced acute kidney injury after percutaneous coronary intervention in patients with chronic kidney disease. Kim JH, Yang JH, Choi SH, Song YB, Hahn JY, Choi JH, Lee SH, Gwon HC. Am J Cardiol; 2014 Dec 15; 114(12):1830-5. PubMed ID: 25438909 [Abstract] [Full Text] [Related]
7. Incidence, Predictors, and Impact on Six-Month Mortality of Three Different Definitions of Contrast-Induced Acute Kidney Injury After Coronary Angiography. Guillon B, Ecarnot F, Marcucci C, Ducloux D, Chatot M, Badoz M, Bonnet B, Chopard R, Frey P, Meneveau N, Schiele F. Am J Cardiol; 2018 Apr 01; 121(7):818-824. PubMed ID: 29397881 [Abstract] [Full Text] [Related]
15. Acute kidney injury based on the KDIGO criteria among ST elevation myocardial infarction patients treated by primary percutaneous intervention. Margolis G, Gal-Oz A, Letourneau-Shesaf S, Khoury S, Keren G, Shacham Y. J Nephrol; 2018 Jun 01; 31(3):423-428. PubMed ID: 29185210 [Abstract] [Full Text] [Related]
19. Combined impact of chronic kidney disease and contrast-induced nephropathy on long-term outcomes in patients with ST-segment elevation acute myocardial infarction who undergo primary percutaneous coronary intervention. Nakahashi H, Kosuge M, Sakamaki K, Kiyokuni M, Ebina T, Hibi K, Tsukahara K, Iwahashi N, Kuji S, Oba MS, Umemura S, Kimura K. Heart Vessels; 2017 Jan 01; 32(1):22-29. PubMed ID: 27106917 [Abstract] [Full Text] [Related]
20. Short-term rosuvastatin therapy for prevention of contrast-induced acute kidney injury in patients with diabetes and chronic kidney disease. Han Y, Zhu G, Han L, Hou F, Huang W, Liu H, Gan J, Jiang T, Li X, Wang W, Ding S, Jia S, Shen W, Wang D, Sun L, Qiu J, Wang X, Li Y, Deng J, Li J, Xu K, Xu B, Mehran R, Huo Y. J Am Coll Cardiol; 2017 Jan 01; 63(1):62-70. PubMed ID: 24076297 [Abstract] [Full Text] [Related] Page: [Next] [New Search]